Clomipramine
Clomipramine, sold under the brand name Anafranil among others, is a tricyclic antidepressant (TCA). It is used for the treatment of obsessive–compulsive disorder, panic disorder, major depressive disorder, and chronic pain. It may increase the risk of suicide in those under the age of 25. It is taken by mouth. It has also been used to treat premature ejaculation.
Common side effects include dry mouth, constipation, loss of appetite, sleepiness, weight gain, sexual dysfunction, and trouble urinating. Serious side effects include an increased risk of suicidal behavior in those under the age of 25, seizures, mania, and liver problems. If stopped suddenly a withdrawal syndrome may occur with headaches, sweating, and dizziness. It is unclear if it is safe for use in pregnancy. Its mechanism of action is not entirely clear but is believed to involve increased levels of serotonin.
Clomipramine was discovered in 1964 by the Swiss drug manufacturer Ciba-Geigy. It is on the World Health Organization's List of Essential Medicines. It is available as a generic medication. 
Q908843
tricyclic antidepressant
Concept
Q178190
obsessive–compulsive disorder
Concept
Q741713
panic disorder
Concept
Q42844
major depressive disorder
Concept
Q1088113
chronic pain
Concept
Q10737
suicide
Concept
Q319312
premature ejaculation
Concept
Q10737
suicidal behavior
Concept
Q6279182
seizures
Concept
Q185935
mania
Concept
Q10916362
dizziness
Concept
Q167934
serotonin
Concept
Q507154
Ciba-Geigy
ORG
Q37155
World Health Organization's List of Essential Medicines
MEDIA
Q506319
generic medication
Concept
Q58713
Clomipramine
Concept
Q58713
Clomipramine
Concept
1964-01-01T00:00:00Z^^http://www.w3.org/2001/XMLSchema#dateTime
1964
DATE
+25^^http://www.w3.org/2001/XMLSchema#decimal
25
NUMBER
+25^^http://www.w3.org/2001/XMLSchema#decimal
25
NUMBER
subject has role
medical condition treated
medical condition treated